Aviga Health

Aviga Health  ·  Strategic Advisory

Where Investor Discipline Meets Clinical Conviction

Venture-grade rigor and hands-on clinical experience — for the companies shaping what medical devices become next.

Scroll

15+

Years in Medtech

225+

Investigative Stories

2,000+

Expert Interviews

3

Top-Tier VC Firms

Our Philosophy

Operator Intelligence.
Investor Precision.

Most advisory firms speak the language of either finance or medicine. Aviga Health speaks both. We are a boutique firm built for the convergence of AI, medical device development, and the capital markets funding its growth.

From first-in-human studies to Series B, we work with founding teams, corporate strategics, and institutional investors to sharpen strategy, reduce risk, and move faster toward the moments that matter.

Dual Perspective

Equal comfort at the investor table and the operator's bench — from term sheets to trial protocols.

AI-Native Thinking

A practitioner's understanding of where AI creates durable value in regulated devices — and where it doesn't.

Boutique Accountability

No junior analysts. No templated frameworks. Every engagement is led by a principal who has done this work themselves.

What We Do

Specialized Expertise

End-to-end advisory across the Medtech value chain — from concept to clinical to capital.

Product & Clinical Strategy

Defining the right product for the right market, then building the clinical evidence that commands approval and adoption.

  • Product-Market Fit & Definition
  • Clinical Development Strategy
  • AI Strategy & Integration
  • Market & Whitespace Assessment

Venture Diligence & M&A

Diligence that reads between the lines of any pitch — interrogating clinical feasibility, regulatory pathways, and the real competitive landscape.

  • Strategic M&A Target Evaluation
  • Investor Due Diligence
  • Post-Investment Acceleration
  • Market Models & Forecasting

Strategic Comms & IR

The message underneath the strategy — shaping how investors, partners, and the market understand what you're building.

  • Executive & Strategic Counsel
  • Investor Relations & Fundraising
  • Key Message Development
  • Media & Presentation Training

Clients

Who We Work With

01

Institutional Capital

Venture and private equity firms that need clinical insight alongside financial analysis — to separate genuinely defensible assets from well-packaged ones.

02

Medtech Strategics

Corporate development teams evaluating AI-enabled acquisitions or building new capabilities in-house, where a misjudgment costs years, not just capital.

03

High-Growth Startups

Early-stage teams who need a trusted partner who has navigated the full arc from prototype to FDA clearance — and knows what investors will ask before they ask it.

The right engagement starts before the critical decision, not after.

Reach out to discuss your next engagement.

Schedule a Consultation
Viral Gandhi

Viral Gandhi

Founder & Principal Advisor

linkedin.com/in/gandhiv

Viral Gandhi has been on both sides of the Medtech table: as an investor at three top-tier institutions, and as a founder running his own clinical trials. That combination is uncommon. The perspective it produces is what Aviga is built around.

Venture & Corporate Investment

Most recently Principal at KCK Medtech, following investment roles at Longitude Capital, OrbiMed, and the corporate venture arm of Edwards Lifesciences (NYSE: EW). As a two-time founder — GlucoLens and Aperture Medical — he has lived both the pitch and the build.

Clinical Strategy & Execution

Viral has run clinical programs from first-in-human studies through large-scale randomized trials. He served as VP of Clinical at Revamp Medical and led trial operations for the PARTNER trials at Edwards Lifesciences. His advisory work includes Auris Health, Imperative Care, and Hawthorne Health.

Ecosystem Intelligence

Before investing or operating, Viral led Medtech investigative coverage for the Financial Times Group — publishing 225+ stories and interviewing more than 2,000 industry figures. The pattern recognition and network that built are things no MBA can replicate.

Education

B.S. & M.S. in Bioengineering, University of Pennsylvania  ·  Stanford Biodesign Fellow  ·  Judge and mentor at global industry accelerators.